Tokyo Tape
Sign in
← Gakken Holdings

Quarterly report · Q2

9470.TEDINET S100TE39
Period2023-10-01 → 2024-03-31
Filed2024-05-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥93.5bn2023-10-01 → 2024-03-31Cons.Net sales
Revenue¥164.1bn2022-10-01 → 2023-09-30Cons.Net sales (5-year summary)
Revenue¥81.2bn2022-10-01 → 2023-03-31Cons.Net sales
Operating income¥5.1bn2023-10-01 → 2024-03-31Cons.Operating income
Operating income¥3.2bn2022-10-01 → 2023-03-31Cons.Operating income
Ordinary income¥5.2bn2023-10-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥6.5bn2022-10-01 → 2023-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥3.3bn2022-10-01 → 2023-03-31Cons.Ordinary income
Profit before tax¥3.8bn2023-10-01 → 2024-03-31Cons.Income before income taxes
Profit before tax¥2.6bn2022-10-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥1.8bn2023-10-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥3.2bn2022-10-01 → 2023-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.2bn2022-10-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income¥1.9bn2023-10-01 → 2024-03-31Cons.Profit loss
Net income¥1.3bn2022-10-01 → 2023-03-31Cons.Profit loss
Total assets¥139.4bnat 2024-03-31Cons.Assets
Total assets¥136.3bnat 2023-09-30Cons.Assets
Total assets¥132.2bnat 2023-03-31Cons.Total assets (5-year summary)
Total liabilities¥84.7bnat 2024-03-31Cons.Liabilities
Total liabilities¥81.3bnat 2023-09-30Cons.Liabilities
Net assets / equity¥54.7bnat 2024-03-31Cons.Net assets
Net assets / equity¥55.0bnat 2023-09-30Cons.Net assets
Net assets / equity¥50.6bnat 2023-03-31Cons.Net assets (5-year summary)
Cash and deposits¥23.8bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥20.8bnat 2023-09-30Cons.Cash and deposits
Cash & equivalents¥22.0bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥19.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥24.7bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥21.7bnat 2022-09-30dCons.Cash and cash equivalents
Operating cash flow¥1.6bn2023-10-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥5.5bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥167m2022-10-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Investing cash flow¥3.9bn2023-10-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥4.8bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.1bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥2.5bn2023-10-01 → 2024-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥6.2bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.4bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥41.192023-10-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥42.682024-01-01 → 2024-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥72.512022-10-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.152022-10-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥22.852023-01-01 → 2023-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥40.872023-10-01 → 2024-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥71.92022-10-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥27.92022-10-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio37.5%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio38.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio37.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-10-01 → 2024-03-31¥7.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-10-01 → 2024-03-31¥3.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-10-01 → 2024-03-31¥4.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-10-01 → 2024-03-31¥282m
Reconciling Itemsreconcilingrevenue2023-10-01 → 2024-03-31−¥4.3bn
Reconciling Itemsreconcilingrevenue intersegment2023-10-01 → 2024-03-31−¥4.3bn
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2024-03-31−¥923m
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue2023-10-01 → 2024-03-31¥48.3bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue external2023-10-01 → 2024-03-31¥48.2bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥126m
jpcrp040300-q2r_E00707-000Educationreportable segmentsegment profit2023-10-01 → 2024-03-31¥3.7bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue2023-10-01 → 2024-03-31¥42.2bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue external2023-10-01 → 2024-03-31¥42.1bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥27m
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentsegment profit2023-10-01 → 2024-03-31¥2.1bn
—segment totalrevenue2023-10-01 → 2024-03-31¥90.5bn
—segment totalrevenue external2023-10-01 → 2024-03-31¥90.3bn
—segment totalrevenue intersegment2023-10-01 → 2024-03-31¥153m
—segment totalsegment profit2023-10-01 → 2024-03-31¥5.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-10-01 → 2024-03-31¥97.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-10-01 → 2024-03-31¥93.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-10-01 → 2024-03-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-10-01 → 2024-03-31¥6.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-10-01 → 2023-03-31¥7.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-10-01 → 2023-03-31¥2.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-10-01 → 2023-03-31¥4.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-10-01 → 2023-03-31¥294m
Reconciling Itemsreconcilingrevenue2022-10-01 → 2023-03-31−¥4.8bn
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2023-03-31−¥4.8bn
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-03-31−¥1.0bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue2022-10-01 → 2023-03-31¥40.3bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue external2022-10-01 → 2023-03-31¥40.2bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥116m
jpcrp040300-q2r_E00707-000Educationreportable segmentsegment profit2022-10-01 → 2023-03-31¥2.6bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue2022-10-01 → 2023-03-31¥38.1bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue external2022-10-01 → 2023-03-31¥38.1bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥42m
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentsegment profit2022-10-01 → 2023-03-31¥1.4bn
—segment totalrevenue2022-10-01 → 2023-03-31¥78.4bn
—segment totalrevenue external2022-10-01 → 2023-03-31¥78.3bn
—segment totalrevenue intersegment2022-10-01 → 2023-03-31¥158m
—segment totalsegment profit2022-10-01 → 2023-03-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-10-01 → 2023-03-31¥86.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-10-01 → 2023-03-31¥81.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-10-01 → 2023-03-31¥4.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-10-01 → 2023-03-31¥4.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 536
ItemContextValueUnit
Other clPrior1YearInstant16840000000JPY
Other clCurrentQuarterInstant17361000000JPY
Current liabilitiesPrior1YearInstant44550000000JPY
Current liabilitiesCurrentQuarterInstant51767000000JPY
Bonds payablePrior1YearInstant6000000000JPY
Bonds payableCurrentQuarterInstant－JPY
Long term loans payablePrior1YearInstant19052000000JPY
Long term loans payableCurrentQuarterInstant21107000000JPY
Net defined benefit liabilityPrior1YearInstant4684000000JPY
Net defined benefit liabilityCurrentQuarterInstant4629000000JPY
Other nclPrior1YearInstant7006000000JPY
Other nclCurrentQuarterInstant7158000000JPY
Noncurrent liabilitiesPrior1YearInstant36743000000JPY
Noncurrent liabilitiesCurrentQuarterInstant32896000000JPY
LiabilitiesPrior1YearInstant81294000000JPY
LiabilitiesCurrentQuarterInstant84663000000JPY
Capital stockPrior1YearInstant19817000000JPY
Capital stockCurrentQuarterInstant19817000000JPY
Capital surplusPrior1YearInstant12370000000JPY
Capital surplusCurrentQuarterInstant12368000000JPY
Retained earningsPrior1YearInstant17433000000JPY
Retained earningsCurrentQuarterInstant18655000000JPY
Treasury stockPrior1YearInstant-315000000JPY
Treasury stockCurrentQuarterInstant-2196000000JPY
Shareholders equityPrior1YearInstant49306000000JPY
Shareholders equityCurrentQuarterInstant48645000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant1857000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant2221000000JPY
Deferred gains or losses on hedgesPrior1YearInstant1000000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant-0JPY
Foreign currency translation adjustmentPrior1YearInstant271000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant199000000JPY
Remeasurements of defined benefit plansPrior1YearInstant1310000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant1198000000JPY
Valuation and translation adjustmentsPrior1YearInstant3441000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant3619000000JPY
Subscription rights to sharesPrior1YearInstant229000000JPY
Subscription rights to sharesCurrentQuarterInstant208000000JPY
Non controlling interestsPrior1YearInstant2056000000JPY
Non controlling interestsCurrentQuarterInstant2221000000JPY
Net assetsPrior1YearInstant55034000000JPY
Net assetsCurrentQuarterInstant54694000000JPY
Liabilities and net assetsPrior1YearInstant136328000000JPY
Liabilities and net assetsCurrentQuarterInstant139358000000JPY
Net salesPrior1YTDDuration81174000000JPY
Net salesCurrentYTDDuration93505000000JPY
Cost of salesPrior1YTDDuration57567000000JPY
Cost of salesCurrentYTDDuration67011000000JPY
Gross profitPrior1YTDDuration23606000000JPY
Gross profitCurrentYTDDuration26494000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-09-30pass
balance sheet identityconsolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2023-10-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-10-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-10-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass